Meet Us at Booth X2/11

Taking GI Care Further Together

The digestive category has the second highest level of new cancer cases — and the second highest number of deaths. We’re committed to caring for the large, diverse population of GI patients with products to support them across the continuum of care.

Medtronic is here to help you meet the specific needs of individual patients along their continuum of care.

Scroll down for more information on our products and our recommended sessions throughout UEG Week 2018.

ESGE Learning Area

Get 'hands-on' with Medtronic

23/10, 09:30-11:00 & 14:00-15:30

24/10, 09:30-11:00

We are delighted to invite you to join our Hands-On open sessions focusing on Dysplastic Barrett's Esophagus management, using Medtronic RFA BarrxTM Catheters and Capnography Monitoring

  • Saturday, October 20th 

    14:00-16:30

    PGT: Parallel Session, Room E1 - Gallstones and complications

    PGT: Parallel Session, Room C -  Therapy update in functional gastrointestinal disorders

  • Sunday, October 21st 

    08:30-10:30

    PGT: Parallel Session, Room A: Advanced endoscopic techniques

    PGT: Parallel Session, Room E1: Cystic pancreatic lesions

    11:00-13:00

    PGT: Clinical Case Based Session, Room E2: Management of Barrett's oesophagus and Barrett's neoplasia

    IP093 - ENDOSCOPIC THERAPY OF AN EARLY BARRETT'S CARCINOMA., A. May, Germany

  • Monday, October 22nd

    09:00-17:00

    Poster Session, Hall X1: IBD I

    P0323 - EVALUATION OF CROHN´S DISEASE BY USING A NOVEL CAPSULE ENDOSCOPY SCORING METHOD: CROHN´S DISEASE ACTIVITY IN CAPSULE ENDOSCOPY (CDACE)., T.Omori, Japan

    10:30-12:00

    Symposium, Room E2: Barrett's oesophagus

    IP156 - ENDOSCOPIC MANAGEMENT OF BARRETT'S OESOPHAGUS: ABLATION., P. Sharma, United States, T. Omori, Japan

    Abstract-based Session, Room L7: Interventional EUS: Fifty shades of gray

    12:20-13:30

    Poster Champ Session, E-Poster Terminal 4 (Hall X1): Poster Champ Session: Upper gastrointestinal diseases

    P0520 - SELF-SIZING RADIOFREQUENCY ABLATION BALLOON FOR ERADICATION OF BARRETT´S ESOPHAGUS: RESULTS OF AN INTERNATIONAL MULTICENTER RANDOMIZED TRIAL COMPARING THREE DIFFERENT TREATMENT REGIMENS., K. Belghazi, Netherlands"

    Poster Session, Hall X1: Endoscopy and Imaging I

    P0234 - VIDEOCAPSULE ENDOSCOPY IN UNEXPLAINED IRON DEFICIENCY ANEMIA: A RETROSPECTIVE COHORT STUDY., Antonella Contaldo, Italy; Losurdo G.; Albano F.; Iannone A.; Ierardi E.; Principi M.; Di Leo A."

    12:45 - 13:45

    Case-based Discussion, Room K: Oesophageal motility disorders and dysphagia: How to diagnose? How to treat?

    15:45 - 17:15

    Abstract-based Session, Room K: Management of Barrett's

  • Tuesday, October 23rd

    08:30-10:30 

    Abstract-based Session, Room N2: Small bowel disorders

    OP152 - BOWEL PREPARATION FOR SMALL BOWEL CAPSULE ENDOSCOPY – THE LATER, THE BETTER!, B. Rosa, Portugal"

    Abstract-based Session, Room G: Oesophageal disorders: Mechanisms and management

    09:00-17:00

    Poster Session, Hall X1: Endoscopy and Imaging II

    P0864 - IS PAN-ENTERIC VIDEO CAPSULE ENDOSCOPY A COST-EFFECTIVE OPTION FOR OPTIMIZATION OF CROHN’S DISEASE THERAPY IN ENGLAND?, R. Torrejon Torres, Germany

    Poster Session, Hall X1: IBD II

    P0943 - DIAGNOSTIC YIELD IN THE VISUALIZATION OF CAPSULE ENDOSCOPY BY A TRAINED NURSE., I.K. Araujo Acuña, Spain

    P0869 - THE DIAGNOSTIC YIELD OF SMALL BOWEL CAPSULE ENDOSCOPY IN POSTSURGICAL CROHN’S DISEASE., C. Pontas, Greece

    10:30-12:00

    Symposium, Room E2: From guidelines to clinical practice: Barrett's oesophagus

    IP373 - HOW TO TREAT DYSPLASIA?, E. Coron, France"

    Symposium, Room L8: Contrast-enhanced ultrasound (CEUS) for clinical problem solving: Safer than CT/MR

    12:30-13:30

    Poster Champ Session, E-Poster Terminal 4 (Hall X1): Poster Champ Session: Upper gastrointestinal diseases

    P1162 - THE IMPACT OF THE POLICY-PRACTICE GAP ON COST-EFFECTIVENESS OF BARRETT’S OESOPHAGUS MANAGEMENT., A.-H. Omidvari, Netherlands"

    14:00-15:30

    Symposium, Room G - Therapeutic EUS: Drainage and beyond

  • Wednesday, October 24th

    09:00-14:00 

    Poster Session, Hall X1: Endoscopy and Imaging III

    P1480 - THE COMPARISON OF THE EFFICIENCY OF COLON CAPSULE ENDOSCOPY AND OPTICAL COLONOSCOPY IN PATIENTS WITH POSITIVE IMMUNOCHEMICAL FECAL OCCULT BLOOD TEST., M. Voska, Czech Republic"

    P1476 - ADEQUACY AND DIAGNOSTIC YIELD OF A NOVEL CORE BIOPSY NEEDLE (SHARKCORE FNB NEEDLE) IN THE DIAGNOSIS OF SUBEPITHELIAL LESIONS: OUR SERIES., I. Barbuscio, Italy"

    P1485 - INVESTIGATING IRON-DEFICIENCY ANEMIA WITHSMALL BOWEL CAPSULE ENDOSCOPY: IS HAEMOGLOBIN A RELIABLE PREDICTOR OF POTENTIALLY BLEEDING LESIONS?, B. Rosa, Portugal

    Poster Session, Hall X2/X1: Clinical Cases III

    CC131 - GASTRIC FUNDUS SPLENOSIS PRESENTING AS A STROMAL TUMOR AND DIAGNOSED BY ENDOSCOPIC ULTRASOUND-GUIDED SHARKCORE BIOPSY., I. Barbuscio, Italy

    10:30-12:00

    Symposium, Room N1: How to improve diagnostic accuracy in pancreatobiliary EUS

    14:00-15:30 

    Symposium, Room G: EUS: What's new in 2018?

    IP621 - FNB NEEDLES: WHAT ARE THE ADVANTAGES TO OBTAINING HISTORY SAMPLES?, S. Carrara, Italy"

    Symposium, Room E2: Endoscopy: What's new in 2018?

    IP612 - ENDOSCOPY IN THE SMALL BOWEL., C. Spada, Italy

    Symposium, Room F1: Barrett's oesophagus: What's new in 2018?

    P613 - IS THERE A ROOM FOR NON-INVASIVE TESTING?, M. di Pietro, United Kingdom

    IP614 - IMPROVING NEOPLASIA DETECTION DURING ENDOSCOPY., R. Bisschops, Belgium

    IP615 - IS THERE A NEXT STEP IN ENDOSCOPIC MANAGEMENT?, J.J. Bergman, Netherlands

    IP616 - SURVEILLANCE AND WHEN TO REFER., B.L. Weusten, Netherlands

Visualize with confidence

Discover how the PillCamTM capsule endoscopy platform enables comprehensive GI tract imaging.

The PillCam™ capsule endoscopy platform uses innovative visualization technology to produce clear images of the digestive tract. This noninvasive platform allows physicians to detect GI abnormalities, monitor disease activity, and assess treatment efficacy([FOOTNOTE=User Manual (DOC-2044-02 March 2013), page 3, 123.],[ANCHOR=],[LINK=])

The Goal of Intervention is to prevent disease progression([FOOTNOTE=Whiteman DC, et al. Australian clinical practice guidelines for the diagnosis and management of Barrett's esophagus and early esophageal adenocarcinoma. J Gastroenterol Hepatol 2015; 30: 804-20.],[ANCHOR=],[LINK=])

BarrxTM Endoscopic RFA Therapy

  • Barrx™ RFA has a better safety and side-effect profile than other ablative techniques([FOOTNOTE=Fitzgerald RC, et al. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus. Gut 2014; 63: 7-42.],[ANCHOR=],[LINK=])
  • RFA significantly eliminates Barrett’s tissue and reduces neoplastic progression to HGD/cancer compared to surveillance in confirmed LGD patients([FOOTNOTE=Phoa et al, Radiofrequency ablation vs endoscopic surveillance for patients with Barrett esophagus and low-grade dysplasia: a randomized clinical trial JAMA 2014;311:1209-17.],[ANCHOR=],[LINK=])
  • Radiofrequency ablation (RFA) has been shown in two RCT’s to reduce progression to Esophageal Adenocarcinoma (EAC)([FOOTNOTE=Smith CD et al. Endoscopic ablation of intestinal metaplasia containing high-grade dysplasia in esophagectomy patients using a balloon-based ablation system. Surg Endosc 2007;21:560-569.],[ANCHOR=],[LINK=]) , ([FOOTNOTE=Shaheen NJ al. Radiofrequency Ablation in Barrett’s Esophagus with Dysplasia. New England Journal of Medicine. 2009 May;360(22):2277-2288.],[ANCHOR=],[LINK=]) 

Enhanced Tissue Acquisition

Achieve more with the Beacon™ EUS Delivery System

The Beacon™ EUS delivery system features interchangeable FNA and FNB needles designed to support consistent and predictable acquisition of tissue samples with intact cellular architecture.([FOOTNOTE=DDW 2015 Presentations: #935. A Novel EUS-guided Liver Biopsy Needle is Superior to 19-G Core and FNA Needles: Examining the Effect of Needle Design, Number of Excursions, and Variable Suction Parameters on Histologic Yield. Schulman A, Thompson C, Chan W, Ryou M. #Tu1638. Initial experience with a novel EUS-guided core biopsy needle (SharkCore™): a North American multicenter study. DiMaio C, Kolb J, Benias P, et al. #Tu1648. Evaluating The Efficacy of a New FDA Approved EUS Core Biopsy Needle and Different Fine Needle Biopsy (FNB) Techniques To Yield The Best Core Specimen In a Live Porcine Model. Shivangi Kothari S, Kothari T, Zhou Z, et al.],[ANCHOR=],[LINK=]) , ([FOOTNOTE=Based on product development testing data. Data on file. (See Report #1085 and Report #1090).],[ANCHOR=],[LINK=])

The components of this innovative EUS delivery system are interchangeable, supporting greater efficiency([FOOTNOTE=Enestvedt B, Maranki, J, Makipour K, Mathur M, Haluszka O. Is Two Better Than One? a Comparison of EUS-FNA Efficiency of Single- vs Multi-Needle Platforms. Gastrointestinal Endoscopy. 2013;77(5S):AB179.],[ANCHOR=],[LINK=]), while built-in safety features help protect healthcare staff from needle stick injury. And with advanced needles that help improve biopsy yield13,15, interventional endoscopists and pathologists can potentially increase diagnostic rates.14,15

Managing the risks of Procedural Sedation

Discover Capnography Monitoring

Moderate to deep sedation is very common during G.I. procedure, but associated with risk.

Some of the drugs usually administered have a potential respiratory depressant effect that may induce hypoventilation or airway obstruction and compromise the vital functions.

When changes to ventilation are not observed or noticed, the patient condition may deteriorate very rapidly, especially when the patient has significant comorbidities.

Recent clinical evidence and European guidelines detail how Capnography monitoring can help to manage the risk of Respiratory Compromise during G.I. Procedural Sedation.

Predictability. Now it's possible.

EmprintTM Ablation System, Powered by ThermosphereTM Technology

The EmprintTM ablation system powered by ThermosphereTM technology delivers that predictability. With three kinds of spatial energy control - thermal, field, and wavelenght - it produces precise spherical ablation zones. It's ablatiion you can count on. So the only thing to imagine is how it can transform your patient's lives.

Detect Early. Treat Early.

Endoflip™ Impedance Planimetry System

Measure pressure and dimensions in the esophagus, pylorus, and anal sphincters with a patient-friendly solution.

The Endoflip™ impedance planimetry system transforms the way you evaluate symptoms consistent with motility disorders and helps you minimize patient discomfort.([FOOTNOTE=Gyawali CP, Bredenoord AJ, Conklin JL, Fox M, Pandolfino JE, Peters JH, Roman S, Staiano A, Vaezi MF. Evaluation of esophageal motor function in clinical Practice. Neurogastroenterol Motil 2013;25(2):99-133.],[ANCHOR=],[LINK=]) , ([FOOTNOTE=Carlson DA, Lin Z, Kahrilas PJ, Sternbach J, Donnan EN, Friesen L, Listernick Z, Mogni B, Pandolfino JE. The Functional Lumen Imaging Probe Detects Esophageal Contractility Not Observed With Manometry in Patients With Achalasia. Gastroenterology 2015;149(7):1742-1751.],[ANCHOR=],[LINK=]) , ([FOOTNOTE=Carlson DA, Kahrilas PJ, Lin Z, Hirano I, Gonsalves N, Listernick Z, Ritter K, Tye M, Ponds FA, Wong I, Pandolfino JE. Evaluation of Esophageal Motility Utilizing the Functional Lumen Imaging Probe. Am J Gastroenterol 2016;111(12):1726-1735.],[ANCHOR=],[LINK=])

This advanced imaging technology provides an internal view of the gastroesophageal (GE) junction during endoscopic and surgical procedures.

Real-time measurements of the pressure and dimensions in the esophagus, and other sphincters of the alimentary canal, help you identify major motility disorders.